Switch theme
Sign up to access all valuation multiples
Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
2008
9
Last FY Revenue $0.4M
Last FY EBITDA -$4.3M
$19.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Predilife achieved revenue of $0.4M and an EBITDA of -$4.3M.
Predilife expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Predilife valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.4M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 97% | XXX | XXX | XXX |
| EBITDA | XXX | -$4.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -1201% | XXX | XXX | XXX |
| EBIT | XXX | -$4.3M | XXX | XXX | XXX |
| EBIT Margin | XXX | -1208% | XXX | XXX | XXX |
| Net Profit | XXX | -$4.7M | XXX | XXX | XXX |
| Net Margin | XXX | -1327% | XXX | XXX | XXX |
| Net Debt | XXX | $5.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Predilife's stock price is EUR 4 (or $4).
Predilife has current market cap of EUR 14.3M (or $16.1M), and EV of EUR 17.5M (or $19.6M).
See Predilife trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19.6M | $16.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Predilife has market cap of $16.1M and EV of $19.6M.
Predilife's trades at 55.0x EV/Revenue multiple, and -4.6x EV/EBITDA.
Equity research analysts estimate Predilife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Predilife's P/E ratio is not available.
See valuation multiples for Predilife and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $16.1M | XXX | $16.1M | XXX | XXX | XXX |
| EV (current) | $19.6M | XXX | $19.6M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 55.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -4.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -4.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -3.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -4.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPredilife's revenue per employee in the last FY averaged $40K, while opex per employee averaged $0.5M for the same period.
Predilife's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Predilife's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Predilife and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -1201% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $40K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 1305% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Predilife acquired XXX companies to date.
Last acquisition by Predilife was XXXXXXXX, XXXXX XXXXX XXXXXX . Predilife acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Predilife founded? | Predilife was founded in 2008. |
| Where is Predilife headquartered? | Predilife is headquartered in France. |
| How many employees does Predilife have? | As of today, Predilife has 9 employees. |
| Is Predilife publicy listed? | Yes, Predilife is a public company listed on PAR. |
| What is the stock symbol of Predilife? | Predilife trades under ALPRE ticker. |
| When did Predilife go public? | Predilife went public in 2018. |
| Who are competitors of Predilife? | Similar companies to Predilife include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Predilife? | Predilife's current market cap is $16.1M |
| Is Predilife profitable? | Yes, Predilife is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
